Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection47
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective31
The making of the one pill—Developing single tablet regimens for HIV and for HCV24
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting21
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation17
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants16
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts16
Cost-effectiveness of tenofovir alafenamide fumarate for treatment of chronic hepatitis B: Evidence from a tertiary hospital in Vietnam14
A rare complication of coronary vasospasm associated with concomitant use of ergotamine, cobicistat, and darunavir13
Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study13
Commentary: John C. Martin (1951–2021)13
In-silico approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity12
0.32778096199036